Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ICGEB CRP Research Grants

International Centre for Genetic Engineering and Biotechnology

The ICGEB CRP Grants programme was established in 1988 and aims to stimulate collaborative research in Member States and with the ICGEB Component laboratories, promote training of young scientists, and facilitate the creation of appropriate research facilities. The programme supports research projects in basic science, human healthcare, industrial and agricultural biotechnology and bioenergy. A call for applications is launched yearly.

Grants are awarded to contribute to the implementation of outstanding scientific research projects. An important element of successful applications is the feasibility of the proposed project within the designated timeframe (maximum 36 months). The maximum annual contribution from ICGEB is Euro 25,000.

Specialties

Biochemistry

Cell Biology

Molecular Biology

Biomedical Engineering

Genetics & Genomics

Technology Development

Eligibility Requirements

Applicants for research grant proposals (identified as “CRPs”) should hold positions at Universities or Research Institutes in any of the ICGEB Member States.

International collaboration is an essential feature of all ICGEB grants and must be fully integrated into the project, detailing the exact role of the collaborators and explaining why this collaboration is relevant for the success of the project. Collaboration with any of the ICGEB groups (in Trieste, New Delhi or Cape Town) is not a mandatory requirement for the grants but is considered an additional asset. Particular attention will be given to: i) projects addressing issues of interest for specific geographic regions; ii) projects presented by groups collaborating across more than one country; iii) projects entailing new rather than existing collaboration; and iv) projects involving ICGEB PIs in the three components.

Investigating groups do not qualify for submission of applications:

if previously awarded projects have not been evaluated and satisfactorily concluded;
if the University or Research Institute of the Principal Investigator is based in Italy.

A special category of CRP-ICGEB Early Career Return Grants is intended to fund young researchers with an outstanding track record, who have spent min. 2 years abroad and have recently returned to an ICGEB Member State to establish independent laboratories.
Applicants for Early Career Return Grants should be no more than 40 years of age at the time of application.
Applicants should have returned to an ICGEB Member State (except Italy) no more than 2 years before applying.

Sponsor Details

Sponsor Institute/Organizations: International Centre for Genetic Engineering and Biotechnology

Sponsor Type:

Address: International Centre for Genetic Engineering and Biotechnology, Area Science Park, Padriciano 99, 3414

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity